• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用临床试验人群和儿童肿瘤学组的数据进行癌症生存者研究。

Leveraging Clinical Trial Populations and Data from the Children's Oncology Group for Cancer Survivorship Research.

机构信息

Fred Hutchinson Cancer Center, University of Washington, Seattle Children's Hospital, Seattle, Washington.

Benioff Children's Hospitals, University of California, San Francisco, California.

出版信息

Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1675-1682. doi: 10.1158/1055-9965.EPI-22-0125.

DOI:10.1158/1055-9965.EPI-22-0125
PMID:35732489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9444937/
Abstract

Children and adolescents diagnosed with cancer can now expect an average 85% 5-year overall survival, with significant improvements in longer-term morbidity and mortality reported over the past several decades. However, the long-term impact of therapeutic agents and modalities introduced in recent years remains unclear and will require dedicated follow-up in the years ahead. The Children's Oncology Group (COG), a part of the NCI's National Clinical Trials Network, with over 200 sites across North America and beyond, enrolls more than 10,000 patients onto research protocols annually, inclusive of first-line clinical trials and nontherapeutic studies. COG provides a platform to conduct survivorship research with several unique strengths: (i) a huge catchment to ascertain relatively rare but important adverse events, (ii) study populations that are otherwise too rare to study in smaller consortia, including access to highly diverse patient populations, (iii) long-term follow-up of clinical trial populations linked to the original trial data, and (iv) a natural platform for intervention research. Enhancements in COG infrastructure facilitate survivorship research, including a COG patient registry (Project:EveryChild), availability of a long-term follow-up tracking resource, and successful deployment of various remote-based study procedures to reduce the burden on participants and participating institutions.

摘要

现在,被诊断患有癌症的儿童和青少年的平均 5 年总生存率预计为 85%,在过去几十年中,报告的长期发病率和死亡率有了显著改善。然而,近年来引入的治疗药物和方法的长期影响尚不清楚,未来几年需要专门进行随访。儿童肿瘤学组(COG)是美国国立卫生研究院国家临床试验网络的一部分,在北美及其他地区拥有 200 多个站点,每年有超过 10000 名患者参与研究方案,包括一线临床试验和非治疗性研究。COG 提供了一个进行生存研究的平台,具有几个独特的优势:(i)一个巨大的收集区,可以确定相对罕见但重要的不良事件,(ii)研究人群否则太稀少,无法在较小的联合会中进行研究,包括获得高度多样化的患者人群,(iii)临床试验人群的长期随访与原始试验数据相关联,以及(iv)干预研究的自然平台。COG 基础设施的增强促进了生存研究,包括 COG 患者登记处(项目:每个孩子),长期随访跟踪资源的可用性,以及各种远程研究程序的成功部署,以减轻参与者和参与机构的负担。

相似文献

1
Leveraging Clinical Trial Populations and Data from the Children's Oncology Group for Cancer Survivorship Research.利用临床试验人群和儿童肿瘤学组的数据进行癌症生存者研究。
Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1675-1682. doi: 10.1158/1055-9965.EPI-22-0125.
2
Cancer survivorship practices, services, and delivery: a report from the Children's Oncology Group (COG) nursing discipline, adolescent/young adult, and late effects committees.癌症生存实践、服务和提供:来自儿童肿瘤学组(COG)护理学科、青少年/年轻成人和晚期效应委员会的报告。
J Cancer Surviv. 2011 Dec;5(4):345-57. doi: 10.1007/s11764-011-0192-8. Epub 2011 Sep 6.
3
Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology.儿童肿瘤学组 2023 年研究蓝图:青少年和青年肿瘤学。
Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30564. doi: 10.1002/pbc.30564. Epub 2023 Jul 13.
4
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group.将美国国家癌症研究所资助的肿瘤协作组数据与行政数据源合并,以开发更有效的临床试验分析和比较效果研究平台:来自儿童肿瘤学组的报告。
Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2(Suppl 2):37-43. doi: 10.1002/pds.3241.
5
The Children's Oncology Group: Organizational Structure, Membership, and Institutional Characteristics.儿童肿瘤研究组:组织结构、成员构成及机构特征
J Pediatr Oncol Nurs. 2019 Jan/Feb;36(1):24-34. doi: 10.1177/1043454218810141. Epub 2018 Nov 14.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Children's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology.儿童肿瘤学组 2013 年研究蓝图:青少年及青年肿瘤学。
Pediatr Blood Cancer. 2013 Jun;60(6):1055-8. doi: 10.1002/pbc.24431. Epub 2012 Dec 19.
9
Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center.国立癌症研究所指定的综合性癌症中心的长期癌症幸存者护理模式
Am J Clin Oncol. 2017 Dec;40(6):639-643. doi: 10.1097/COC.0000000000000217.
10
The project data sphere initiative: accelerating cancer research by sharing data.项目数据领域计划:通过数据共享加速癌症研究
Oncologist. 2015 May;20(5):464-e20. doi: 10.1634/theoncologist.2014-0431. Epub 2015 Apr 15.

引用本文的文献

1
The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A Review.儿童肿瘤学组关于儿童、青少年和青年癌症幸存者的长期随访指南:综述
JAMA Oncol. 2025 May 1;11(5):544-553. doi: 10.1001/jamaoncol.2024.6812.
2
Feasibility and acceptability of a parent-child intervention to improve step count in childhood cancer survivors exposed to cardiotoxic therapy: The STEP UP for FAMILIES Study.改善曾接受过心脏毒性治疗的儿童癌症幸存者步数的亲子干预措施的可行性和可接受性:STEP UP for FAMILIES 研究。
Pediatr Blood Cancer. 2024 Dec;71(12):e31320. doi: 10.1002/pbc.31320. Epub 2024 Sep 17.

本文引用的文献

1
An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report.43,110 名入组儿童肿瘤研究网络的患者的最新评估:儿童肿瘤学组报告。
Cancer. 2022 Jul 15;128(14):2760-2767. doi: 10.1002/cncr.34248. Epub 2022 Apr 28.
2
Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group.儿童癌症幸存者的心脏代谢风险:来自儿童肿瘤学组的报告。
Cancer Epidemiol Biomarkers Prev. 2022 Mar 1;31(3):536-542. doi: 10.1158/1055-9965.EPI-21-0360.
3
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.
多柔比星心脏毒性防护剂(右雷佐生)治疗后的晚期健康结局:来自儿童肿瘤协作组的报告。
Cancer. 2022 Feb 15;128(4):788-796. doi: 10.1002/cncr.33974. Epub 2021 Oct 13.
4
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.胚系癌症易感性变异在儿科横纹肌肉瘤中的作用:来自儿童肿瘤协作组的报告。
J Natl Cancer Inst. 2021 Jul 1;113(7):875-883. doi: 10.1093/jnci/djaa204.
5
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma.贫困与靶向免疫治疗:高危神经母细胞瘤儿童肿瘤组临床试验中的生存情况。
J Natl Cancer Inst. 2021 Mar 1;113(3):282-291. doi: 10.1093/jnci/djaa107.
6
Nearly Half of Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children's Oncology Group.骨肉瘤患者中近半数预测为致病性的胚系变异是新发的:来自儿童肿瘤学组的报告。
JCO Precis Oncol. 2020 Oct 2;4. doi: 10.1200/PO.20.00087. eCollection 2020.
7
The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer.癌症女性抗苗勒管激素的临床价值与解读。
Front Endocrinol (Lausanne). 2020 Oct 7;11:574263. doi: 10.3389/fendo.2020.574263. eCollection 2020.
8
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.美国国立卫生研究院资助的心脏肿瘤学研究的不断发展的设计,以解决癌症治疗相关的心血管毒性。
JACC CardioOncol. 2019 Sep;1(1):105-113. doi: 10.1016/j.jaccao.2019.08.007. Epub 2019 Sep 24.
9
Standardizing Risk Assessment for Treatment-Related Gonadal Insufficiency and Infertility in Childhood Adolescent and Young Adult Cancer: The Pediatric Initiative Network Risk Stratification System.儿童、青少年和青年癌症治疗相关性腺功能不全和不孕症的风险评估标准化:儿科倡议网络风险分层系统
J Adolesc Young Adult Oncol. 2020 Dec;9(6):662-666. doi: 10.1089/jayao.2020.0012. Epub 2020 May 26.
10
Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.GSTM1 缺失变异与儿童癌症后蒽环类药物相关心肌病的关联:儿童肿瘤学组 ALTE03N1 报告。
Cancer. 2020 Sep 1;126(17):4051-4058. doi: 10.1002/cncr.32948. Epub 2020 May 15.